ALMS
(NASDAQ)Alumis Inc.
$24.17-- (--)
Loading... - Market loading
Alumis (ALMS) Stock Price & Financial Analysis
Alumis Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$22.21 - $24.70
52-Week High$31.35
52-Week Low$3.76
Open$22.98
Volume929.43K
Average Volume (3M)1.02M
Market Cap3.00B
Shares Outstanding125.05M
Price to Sales (P/S)379.53
Price to Book (P/B)5.62
EV/EBITDA-7.15
Revenue (TTM)8.40M
Net Income (TTM)-237.41M
Free Cash Flow (TTM)-377.03M
EPS (TTM)$-2.31
Profit Margin-2825.70%
Operating Margin-5364.02%
Return on Equity (ROE)-41.87%
Debt to Equity0.06
50-Day MA$26.20
200-Day MA$21.26
52-Week Change425.77%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$22.21 - $24.70
52-Week High$31.35
52-Week Low$3.76
Open$22.98
Volume929.43K
Average Volume (3M)1.02M
Market Cap3.00B
Shares Outstanding125.05M
Price to Sales (P/S)379.53
Price to Book (P/B)5.62
EV/EBITDA-7.15
Revenue (TTM)8.40M
Net Income (TTM)-237.41M
Free Cash Flow (TTM)-377.03M
EPS (TTM)$-2.31
Profit Margin-2825.70%
Operating Margin-5364.02%
Return on Equity (ROE)-41.87%
Debt to Equity0.06
50-Day MA$26.20
200-Day MA$21.26
52-Week Change425.77%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Alumis
What is the current stock price for ALMS?
As of the latest trading session, ALMS stock trades at $24.17. The 52-week range is $3.76–$31.35, with a day range of $22.21–$24.70.
What is the P/E ratio for ALMS?
The P/E ratio (Price-to-Earnings) for ALMS is shown in the Key Statistics section. This valuation metric helps compare Alumis Inc. to industry peers.
Does ALMS pay dividends?
Alumis does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALMS?
Based on 3 analysts, the consensus for ALMS is Buy.
What is the market cap of ALMS?
Alumis's market capitalization is $3.02B, classifying it as a mid-cap company. Alumis operates in the Healthcare sector within the Biotechnology industry.